Using negative pressure therapy to improve healing in high-risk fractures
Official title: Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures: A Multicenter Randomized Controlled Trial
Run by Major Extremity Trauma Research Consortium · NCT06337292 · Data updated 2026-11-12
This study is testing if a special type of wound therapy can help people with high-risk tibial fractures heal better and avoid infections compared to regular bandages.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 352 (estimated) |
| Sponsor | Major Extremity Trauma Research Consortium Academic / other |
| Locations | 6 sites (Baltimore, Maryland and 5 other locations) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | September 30, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT06337292 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with high-risk open or closed tibial plateau or pilon fractures requiring surgical intervention.
✕Probably not a fit
Patients with low-risk fractures or those not requiring surgical intervention may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of incisional negative pressure wound therapy (NPWT) compared to standard wound dressing in patients with high-risk tibial fractures. It involves a multi-center, randomized controlled design with 352 participants who will be monitored for clinical outcomes three months post-treatment. The study aims to assess the incidence of infections and complications associated with wound healing in this patient population. The primary outcome is a composite measure of clinical status, while secondary outcomes will evaluate individual components of the primary outcome.
Why it matters
Potential benefit: If successful, this approach could significantly reduce infection rates and complications in patients with high-risk fractures.
How similar studies have gone: Previous studies have shown promising results with negative pressure wound therapy in various surgical contexts, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All open or closed tibial plateau or pilon fractures treated operatively with internal fixation at high risk for complication. Any open Gustilo Type I, II or IIIA tibial shaft fracture treated definitively with internal or external fixation with or without ipsilateral leg compartment syndrome if at least one wound is primarily closed. 2. We define high-risk fractures as those that are either: * Closed fracture initially treated with an external fixator (with or without limited internal fixation) and treated definitive more than 3 days later after swelling has resolved; * Any open type I, II or IIIA fracture, regardless of timing of definitive treatment; * Any tibial plateau fracture associated with ipsilateral leg compartment syndrome fasciotomy wounds that has at least one wound primarily closed 3. Requiring incision for fixation or debridement of 3 cm or greater. 4. Patients 18 years of age or older Exclusion Criteria: 1. The study injury is already infected at time of study enrollment. 2. Patient is unable to receive incisional NPWT for any reason. 3. Patients who have already had definitive fixation prior to enrollment in the study. 4. Severe problems with maintaining follow-up (e.g., patients who are homeless at the time of injury or those who are intellectually challenged without adequate family support or who are prisoners). 5. The study injury is a Gustilo Type IIIB or IIIC open fracture.
Where it's running
-
University of Maryland R Adams Cowley Shock Trauma Center
Baltimore, Maryland, United States Recruiting -
University of Maryland Shock Trauma/Capitol Regions
Baltimore, Maryland, United States Recruiting -
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States Recruiting -
Vanderbilt University
Nashville, Tennessee, United States Recruiting -
UTHealth/McGovern Medical School
Houston, Texas, United States Recruiting -
Inova Fairfax MEdical Campus
Falls Church, Virginia, United States Recruiting
Study contacts
- Principal investigator: I. Leah Gitajn, MD — Dartmouth-Hitchcock Medical Center
- Study coordinator: Leah Gitajn, MD
- Email: ida.leah.gitajn@hitchcock.org
- Phone: 603-650-5133
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prophylactic subcutaneous drainage after gynecologic cancer surgery
This study tests whether placing a small drain under the skin after gynecologic cancer surgery helps prevent wound problems in women with thicker tissue under the skin.
-
Steri-Strips added to standard wound closure after cesarean delivery
This study tests whether adding Steri-Strips after a C-section helps reduce wound problems for pregnant patients.
-
PAW-hydrogel to help chronic wounds like diabetic foot and leg ulcers heal faster
This trial will test whether a plasma-activated water–infused Carbopol® 940 hydrogel helps adults with long-standing wounds (diabetic foot, pressure, venous, arterial, or dehiscent ulcers) heal faster and have less bacteria compared with standard advanced wound care.
-
Vacuum Sealing Drainage to Help Wound Healing After Ob/Gyn Surgical Site Infections
This study tests whether Vacuum Sealing Drainage (VSD) helps wounds heal faster and reduces complications after obstetric or gynecologic surgeries when infections occur.
-
PowerHeal Bioelectric Bandage for infected open wound recovery
This tests whether the PowerHeal™ Bioelectric Bandage helps adults with infected traumatic wounds heal faster and clear infection better than standard dressings.
-
Antibacterial absorbable polyester dressing for chronic non-healing wounds
This trial will test an antimicrobial absorbable polyester dressing to see if it helps adults with chronic non-healing ulcers heal faster and safely.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.